Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
Approximately 50% of all colorectal cancer (CRC) patients will develop metastasis to the liver. 90Y selective internal radiation therapy (SIRT) is an established treatment for metastatic CRC. There is still a fundamental lack of understanding regarding the radiobiology underlying the dose response....
Main Authors: | Lee, B, Abbott, E, Able, S, Thompson, J, Hill, M, Kartsonaki, C, Vallis, K, Falzone, N |
---|---|
Format: | Journal article |
Published: |
IOP Publishing
2019
|
Similar Items
-
The impact of radiobiologically-informed dose prescription on the clinical benefit of yttrium-90 SIRT in colorectal cancer patients
by: Abbott, EM, et al.
Published: (2020) -
Combining external beam radiation and radionuclide therapies: rationale, radiobiology, results, and roadblocks
by: Abbott, E, et al.
Published: (2021) -
Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres
by: Arnaud Dieudonné, et al.
Published: (2022-09-01) -
Dosimetric analysis of individual liver metastases from colorectal cancer following 90 y microsphere selective internal radiation therapy
by: Abbott, E, et al.
Published: (2017) -
Mapping the landscape of Y90 radioembolisation research: a citation analysis of the top 100 papers
by: Hassan Mahmood, et al.
Published: (2024-08-01)